Addyi was first authorised with the FDA in August 2015 to treat hypoactive sexual wish ailment (HSDD) in premenopausal Females. That's just yet another way of claiming it boosts sex push (also called libido) in women which have not attained menopause. It was the first these drug accepted for this https://izmiracilcilingir.com/